Esophageal Squamous Cell Carcinoma Clinical Trials in Shanghai
9 recruitingShanghai, China
Showing 1–9 of 9 trials
Recruiting
Phase 2
Vebrekotuzumab ± Anti-PD-1 in Pretreated Advanced ESCC
Esophageal Squamous Cell Carcinoma
Fudan University104 enrolled1 locationNCT07403136
Recruiting
Phase 2
Study of Volrustomig as Monotherapy or in Combination With Anti- Cancer Agents in Participants With Advanced/Metastatic Solid Tumors
Sub-study 1 Cervical Cancer (Volrustomig Monotherapy)Sub-study 2 Head and Neck Squamous Cell Carcinoma (Volrustomig Monotherapy)Sub-study 3 Head and Neck Squamous Cell Carcinoma (Volrustomig in Combination With Chemotherapy)+2 more
AstraZeneca257 enrolled59 locationsNCT06535607
Recruiting
Phase 2
Radiotherapy Combined With Immunochemotherapy in Metastatic Esophageal Squamous Cell Carcinoma
Esophageal CancerEsophageal Squamous Cell CarcinomaMetastatic Esophageal Squamous Cell Carcinoma
Shanghai Chest Hospital100 enrolled2 locationsNCT05978193
Recruiting
Phase 3
Camrelizumab Plus Neoadjuvant Chemotherapy or Chemoradiotherapy Versus Chemoradiotherapy in Resectable ESCC.
Resectable Esophageal Squamous Cell Carcinoma
Zhigang Li426 enrolled5 locationsNCT05043688
Recruiting
Not Applicable
TPF Concurrent Chemo-radiotherapy Plus Immunotherapy for Local Advanced Esophageal Squamous Cell Carcinoma
Esophageal Squamous Cell Carcinoma
Fudan University50 enrolled1 locationNCT06401447
Recruiting
Phase 3
Local Therapy for Oligometastatic ESCC Patients Treated With PD-1 Inhibitor
Esophageal Squamous Cell CarcinomaOligometastatic DiseaseRadiotherapy
Fudan University354 enrolled1 locationNCT06190782
Recruiting
Phase 1Phase 2
Immunotherapy in Combination With Chemoradiotherapy in Unresectable Locally Advanced Esophageal Cancer
Esophageal Squamous Cell CarcinomaUnresectable Locally Advanced Esophageal Cancer
Shanghai Chest Hospital50 enrolled1 locationNCT06173986
Recruiting
Not Applicable
A Study of IO Plus Radiotherapy in Patients With Advanced ESCC.
Metastatic Esophageal Squamous Cell Carcinoma
Fudan University100 enrolled1 locationNCT05760391
Recruiting
Phase 2Phase 3
Neoadjuvant Immunotherapy Plus CRT Versus Neoadjuvant CRT for Locally Advanced Resectable ESCC
Esophageal Squamous Cell Carcinoma Stage IIEsophageal Squamous Cell Carcinoma Stage III
Shanghai Zhongshan Hospital176 enrolled1 locationNCT04973306